Producers shown on SFDA

(Record date:24/08/2021）

Producers shown on EP

(Quoted from EP website；record date:24/08/2021）

Producer: Zhejiang Chengyi Pharmaceutical Co., Ltd founded in 1966, is a comprehensive modern pharmaceutical company, specialized in professional production of capsules, injections, tablets, APIs and pharmaceutical intermediates. It is one of the national key high-tech enterprises, the national high credibility units, provincial and municipal key enterprises, and the leading enterprises in Dongtou District. On March 15, 2017, it was listed on the main board of the Shanghai Stock Exchange.

The company can produce more than 60 kinds, nearly hundred standards of drugs. All products have got the National GMP certification, a number of products get the certification from the United States FDA, EU EMEA, Australia TGA, the United Kingdom MHRA, Mexico Cofepris and some other countries.

Staff size:About 690 person

Registered capital:RMB 233 million 800 thousand

Producer:Zhejiang Huahai Pharmaceutical Co., Ltd.was founded in 1989 and headquartered in Zhejiang, China. The company has nearly 7000 employees and more than 40 subsidiaries around the world (including China, the United States, Japan, Germany, etc.As a leading enterprise in the internationalization of Chinese medicine, Huahai pharmaceutical is the first pharmaceutical company in China to pass the FDA preparation quality certification and independently own the Anda document number. It is also the first Chinese pharmaceutical company to realize large-scale preparation sales in the United States. It has established China's pharmaceutical quality image in the world's high-end pharmaceutical market.

Staff size:About 7000 persons

Registered capital:RMB 1 billion 492 million

---

Producer:Nanjing YOKO biomedical Co., Ltd. is an innovation driven pharmaceutical company. It is a high-tech enterprise integrating R & D, production and marketing with independent intellectual property rights and innovative drug research and development as the core.

Based on the current situation and development trend of the international pharmaceutical market, the company has established the development idea of focusing on the raw materials and related preparations of national class I and II new drugs with independent intellectual property rights, and focusing on the development of anti drug resistant infectious drugs, cardiovascular and cerebrovascular drugs, anti-tumor drugs, tumor adjuvant therapy drugs and consumer therapy drugs, so as to break through drug chemical synthesis Key R & D links and technologies such as pharmacological research. At present, the company has five production workshops that have passed the 2010 GMP certification, including small volume injection workshop, lyophilized powder injection workshop, ordinary solid workshop, sterile sub packaging (cephalosporin) workshop, etc.

Staff size:300-399 persons

Registered capital:RMB 61 million

---

Producer:Hubei Biocause Heilen Pharmaceutical Co., Ltd. was established in December 1995. The company has a number of varieties of pharmaceutical raw materials and preparations, of which the annual production capacity of antipyretic and analgesic raw material ibuprofen is 5000 tons; Our products have customers in more than 80 countries and regions all over the world. In terms of preparations, it has an annual capacity of 1 billion tablets, 300 million capsules and 100 million bags of granules.

Staff size:About 9000 persons

Registered capital:RMB 180 million

---

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +8618402846978